Comparison [acty]
Efficacy [qlco]
Safety [hcpp]
Profile [lbpr]
Morning [tmco]
Administration [ocac]
Controlled release [tmco]
Simvastatin [orch, phsu]
Evening [tmco]
Administration [ocac]
Immediate Release [bodm]
Simvastatin [orch, phsu]
Chronic kidney disease [dsyn]
Patients [podg]
Dyslipidaemia [dsyn]
Purpose [ftcn]
Evening [tmco]
Administration [ocac]
Conventional [qlco]
Immediate Release [bodm]
Formulation [resa]
Simvastatin [orch, phsu]
Recommended [idcn]
short [qlco]
Half-Life [tmco]
1 Hour [tmco]
Health [idcn]
Morning [tmco]
Administration [ocac]
Controlled release [tmco]
Formulation [resa]
Simvastatin [orch, phsu]
Equivalent [qlco]
Lipid [lipd]
lowering [spco]
Efficacy [qlco]
Safety [hcpp]
Profile [lbpr]
Evening [tmco]
Doses [qnco]
Immediate Release [bodm]
Simvastatin [orch, phsu]
Present [qnco]
Study [mnob]
Verify [ftcn]
Safety [hcpp]
Morning [tmco]
Administration [ocac]
Controlled release [tmco]
Simvastatin [orch, phsu]
Evening [tmco]
Administration [ocac]
Immediate Release [bodm]
Simvastatin [orch, phsu]
Patients [podg]
Chronic kidney disease [dsyn]
Dyslipidaemia [dsyn]
Methods [inpr]
Present [qnco]
Study [mnob]
prospective [resa]
DOUBLE BLIND [resa]
Phase IV Trial [resa]
Active Comparator [cnce]
Assigned [ftcn]
Patients [podg]
Chronic kidney disease [dsyn]
Dyslipidaemia [dsyn]
Drug administration [hlca]
Group [idcn]
Morning [tmco]
Administration [ocac]
Controlled release [tmco]
Simvastatin 20 MG [clnd]
Test [lbpr]
Group [idcn]
Evening [tmco]
Administration [ocac]
Immediate Release [bodm]
Simvastatin 20 MG [clnd]
Control Group [grup]
weeks [tmco]
Treatment Outcomes [qlco]
adverse effects [ftcn]
Treatments [topp]
Compared [acty]
findings [ftcn]
Percentage [qnco]
serum LDL [lbpr]
End [spco]
treatment [ftcn]
Test [lbpr]
Group [idcn]
Control Group [grup]
Group [idcn]
Not significant [fndg]
P NOS [aapp, imft]
Percentage [qnco]
Test [lbpr]
Control Groups [grup]
Percentage [qnco]
Total Cholesterol [lbpr]
VS [idcn]
P NOS [aapp, imft]
Triglyceride [bacs, lipd]
VS [idcn]
P NOS [aapp, imft]
HDL-2 [aapp, bacs, lipd]
4 5 [qnco]
P NOS [aapp, imft]
treatment [ftcn]
adverse events [fndg]
Group [idcn]
Events [evnt]
Test [lbpr]
Group [idcn]
Events [evnt]
Control Group [grup]
P NOS [aapp, imft]
Efficacy [qlco]
Morning [tmco]
Administration [ocac]
Controlled release [tmco]
Simvastatin [orch, phsu]
Evening [tmco]
Administration [ocac]
Immediate Release [bodm]
Simvastatin [orch, phsu]
Patients [podg]
Chronic kidney disease [dsyn]
Safety [hcpp]
Profile [lbpr]
Treatments [topp]
Morning [tmco]
Administration [ocac]
Controlled release [tmco]
Simvastatin [orch, phsu]
Expected [idcn]
Patient Compliance [inbe]
Dyslipidaemia [dsyn]
Chronic kidney disease [dsyn]
Patients [podg]
Authors [prog]
Published [ocac]
journals [inpr, mnob]
